News
ERNAW
0.0300
0.00%
0.0000
Ernexa Therapeutics files draft information statement for potential reverse stock split
Reuters · 3d ago
Ernexa targets Q4 2026 start for ERNA-101 Phase 1 ovarian cancer trial
Reuters · 4d ago
Ernexa Therapeutics faces Nasdaq delisting notice after bid price falls below $1 for 30 days
Reuters · 03/20 21:01
ERNEXA THERAPEUTICS INC - MAY OFFER UP TO $50 MLN OF SECURITIES - SEC FILING
Reuters · 03/16 10:01
Ernexa Therapeutics FY 2025 net loss narrows 68% to USD 14.08 million
Reuters · 03/13 21:23
Ernexa Therapeutics CEO Sanjeev Luther to Join Virtual Investor Closing Bell Series Webcast
Reuters · 02/20 14:05
Ernexa Therapeutics Announces Issuance of Warrants in $10.5 Million Public Offering
Reuters · 02/11 22:11
Ernexa Therapeutics Announces $10.5 Million Offering With Warrants to Purchase 21 Million Shares
Reuters · 02/06 14:25
ERNEXA THERAPEUTICS ANNOUNCES PRICING OF $10.5 MILLION PUBLIC OFFERING
Reuters · 02/06 14:25
More
Webull provides a variety of real-time ERNAW stock news. You can receive the latest news about Ernexa Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.